$17.41+0.95 (+5.77%)
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
NRC Health in the Healthcare sector is trading at $17.41. The stock is currently 24% below its 52-week high of $22.79, remaining 11.7% above its 200-day moving average. Technical signals show neutral RSI of 56 and bearish MACD signal, explaining why NRC maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for ...
NRC's Q1 earnings per share decline year over year amid rising costs, though the company delivered revenue growth and strong contract value gains.
NRC Health (NRC) reports a 13% increase in TRCV and unveils a $60 million share repurchase authorization amid strategic expansions.
National Research (NASDAQ:NRC) executives highlighted improving growth trends and a record customer win during the company’s first-quarter 2026 earnings call, pointing to rising recurring contract value, a return to year-over-year revenue growth, and expectations for margin expansion later in the ye
Strong recurring revenues, rising AI adoption and alignment with value-based care trends position NRC to capitalize on growing demand for patient-centric healthcare solutions.
By the end of last week, markets rebounded from the lows, and the S&P 500 and Canadian TSX indexes were positive for the week after negative returns in March. Despite ongoing uncertainty and elevated oil prices, there are signs that de-escalation may be on the horizon. Penny stocks, a term that might seem outdated yet remains significant, represent smaller or newer companies with potential for growth when backed by strong financials. In this article, we explore three penny stocks that combine...